CancerCareE
Online Evaluation
Hematologic Malignancies Specialist
Dr. Qian Li
Associate Chief Physician, Department of Hematology, Tianjin Medical University Cancer Hospital
Specialist in hematologic malignancies with extensive experience in CAR-T therapy and autologous hematopoietic stem cell transplantation for refractory and relapsed hematologic diseases.
Hematologic Malignancies
CAR-T Therapy
Stem Cell Transplantation
Multiple Myeloma
Lymphoma
Leukemia
Neuroblastoma
Working Experience
- Associate Chief Physician, Department of Hematology, Tianjin Medical University Cancer Hospital
- Attending Physician, Blood Transplant Department, Airport Hospital, Tianjin Cancer Hospital
- Master's Thesis Supervisor, Peking Union Medical College
- Member of the Standing Committee, Physicians Branch, Tianjin Medical and Health Education Association
- Member of the Standing Committee, Health Education and Management Professional Committee, Tianjin Medical and Health Society
- Member of the Standing Committee, Hematology Professional Committee, Beijing Chronic Disease Prevention and Health Education Research Association
Areas of Expertise
- Proficient in the diagnosis and treatment of hematologic malignancies, including multiple myeloma, lymphoma, leukemia, and neuroblastoma
- Extensive experience in autologous hematopoietic stem cell transplantation and CAR-T therapy for refractory and relapsed hematologic diseases
- Skilled in managing complex cases of hematologic disorders, integrating cutting-edge therapies such as immunotherapy and targeted treatment
Clinical Experience
Over a Decade of Clinical Practice
Specializing in hematology with focus on high-risk hematologic malignancies
Stem Cell Transplantation
Successfully performed autologous hematopoietic stem cell transplantation for multiple myeloma and lymphoma patients
CAR-T Therapy Applications
Actively involved in clinical applications of CAR-T therapy, contributing to improved outcomes in relapsed leukemia and lymphoma cases
Areas of Scientific Research
- Principal investigator of a National Natural Science Foundation of China Youth Project, focusing on novel therapeutic strategies for hematologic malignancies
- Published more than 10 SCI papers as the first author, emphasizing advancements in multiple myeloma, lymphoma, and CAR-T therapy
- Research interests include translational studies in cellular immunotherapy (CAR-T), gene therapy, and personalized treatment protocols for hematologic diseases
Selected Publications
Advancements in CAR-T Therapy for Refractory Lymphoma
First author, Journal of Hematology & Oncology, 2022
Novel Therapeutic Approaches in Multiple Myeloma
First author, Blood Cancer Journal, 2021
Stem Cell Transplantation Outcomes in Hematologic Malignancies
First author, Bone Marrow Transplantation, 2020
Consult with Dr. Qian Li
Get expert advice on hematologic malignancies, CAR-T therapy and stem cell transplantation
Request Online Evaluation